The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: a national survey
- 1 November 2004
- journal article
- Published by Elsevier in Community Oncology
- Vol. 1 (4) , 211-217
- https://doi.org/10.1016/s1548-5315(11)70825-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapyCancer, 2002
- The level of haemoglobin in anaemic cancer patients correlates positively with quality of lifeBritish Journal of Cancer, 2002
- Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled TrialJournal of Clinical Oncology, 2001
- Chemotherapy-Induced Anemia in Adults: Incidence and TreatmentJNCI Journal of the National Cancer Institute, 1999
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocolAnnals of Oncology, 1993
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesCancer, 1990
- Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.Journal of Clinical Oncology, 1990
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966